OBJECTIVES: The aim of this study was to compare the coping strategies among healthy controls, psychotic and neurotic patients and to evaluate the predictors of suicidal ideation. METHODS: The study population consisted of 115 outpatients in Ulsan University Hospital and 160 healthy controls. They filled out self-report questionnaires including demographics and validated psychiatric scales for depression, perceived stress, coping strategies, and suicide ideation. An analysis of the covariance was used to compare the clinical data among the groups. Stepwise multiple regression analysis was performed to estimate the effects of coping strategies and depression on the risk for suicidal ideation. RESULTS: Compared to the controls, the psychosis group used less active coping, and the neurosis group used more self-blame coping strategies. In healthy controls, suicidal ideation was predicted by depression, female gender, and using more self-blame coping. Although planning in psychosis was a protective factor, acceptance and self-blame in psychosis and behavioral disengagement in neurosis was a risk factor for suicidal ideation. CONCLUSION: Patients with psychotic and neurotic disorders use different coping strategies to deal with their distress and some of those are risk factors for suicidal ideation. Therefore, improving coping skills will be helpful for preventing suicide by alleviating the levels of stress and providing more effective emotion regulation.
Adaptation, Psychological ; Demography ; Depression* ; Female ; Humans ; Neurotic Disorders ; Outpatients ; Protective Factors ; Psychotic Disorders ; Risk Factors ; Suicidal Ideation* ; Suicide ; Ulsan ; Weights and Measures

165Dy Hydroxide Macroaggregates(165Dy HMA) has a short half life(2.3 hours) and a size range of 3-5µm that give the advantage of reduced leakage and a shorter hospital stay. This report will show the results of a prospective open study on the efficacy and safety of 165Dy HMA in 178 knees of 141 patients with chronic synovitis refractory to conventional antirheumatic therapy. The final global assessment was classified as good, fair or poor. Extra-articular leakage of 165Dy HMA was determined by the scintigraphic evaluation of liver, groin and knee joints. The optimum radiation dose was 250 mCi. The mean follow up periods were 32.4(14-112) weeks. Thirty seven percent of the knees showed good results, 48% fair results and 15% poor results. In the knees with stage I radiographic changes, 82% showed improvement including 32% of the patients with good results. In the knees with stage II radiographic changes, 90% showed improvement including 42% of the patients with good results. The mean period of improvement for the 158 knees that responded to treatment was 41.4(24-106) weeks. Leakage of radioactivity from the injected joint was minimal. Adverse reactions were rare(radiation burn : 4 cases, transient postinjection swelling : 14 cases). In conclusion, 165Dy HMA radiation synovectomy is a safe and useful therapy for chromic synovitis of the rheumatoid knees.
Arthritis, Rheumatoid ; Burns ; Follow-Up Studies ; Groin ; Humans ; Injections, Intra-Articular ; Joints ; Knee Joint ; Knee ; Length of Stay ; Liver ; Prospective Studies ; Radioactivity ; Synovitis